ArticleAdvances in radiation oncology2025

Survival Benefit of Combined Chemoimmunotherapy and Radiation Therapy in Patients with Recurrent or Metastatic Esophageal Cancer.

Xueru Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.